INSPIREMD 1/18 DL-0001 Asset Resilience Ratio

Latest as of December 2025: 65.23%

INSPIREMD 1/18 DL-0001 asset resilience ratio. INSPIREMD 1/18 DL-0001 (II2) has an Asset Resilience Ratio of 65.23% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See II2 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€45.27 Million
≈ $52.93 Million USD Cash + Short-term Investments

Total Assets

€69.40 Million
≈ $81.14 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio of INSPIREMD 1/18 DL-0001 (2021–2025)

Asset resilience ratio of INSPIREMD 1/18 DL-0001 from 2021 to 2025. This chart shows how INSPIREMD 1/18 DL-0001's Asset Resilience Ratio has changed over time. Read INSPIREMD 1/18 DL-0001 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down INSPIREMD 1/18 DL-0001's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see INSPIREMD 1/18 DL-0001 asset portfolio.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €45.27 Million 65.23%
Total Liquid Assets €45.27 Million 65.23%

Asset Resilience Insights

  • Very High Liquidity: INSPIREMD 1/18 DL-0001 maintains exceptional liquid asset reserves at 65.23% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

INSPIREMD 1/18 DL-0001 Industry Peers by Asset Resilience Ratio

Compare INSPIREMD 1/18 DL-0001's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
T&L Co. Ltd
KQ:340570
Medical Devices 26.03%
Paxman AB
ST:PAX
Medical Devices -3.83%
VIROMED MEDICAL NA O.N.
XETRA:VME
Medical Devices 0.03%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.48%
Pulsenmore Ltd
TA:PULS
Medical Devices 51.61%
Geratherm Medical AG
XETRA:GME
Medical Devices 34.89%

INSPIREMD 1/18 DL-0001 Asset Resilience Ratio by Year (2021–2025)

INSPIREMD 1/18 DL-0001 asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for INSPIREMD 1/18 DL-0001.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 65.23% €45.27 Million
≈ $52.93 Million
€69.40 Million
≈ $81.14 Million
+31.64pp
2024-12-31 33.59% €15.72 Million
≈ $18.38 Million
€46.81 Million
≈ $54.72 Million
-28.09pp
2023-12-31 61.67% €29.38 Million
≈ $34.35 Million
€47.64 Million
≈ $55.70 Million
+8.25pp
2022-12-31 53.43% €13.17 Million
≈ $15.40 Million
€24.65 Million
≈ $28.82 Million
-2.06pp
2021-12-31 55.49% €22.04 Million
≈ $25.76 Million
€39.71 Million
≈ $46.43 Million
--
pp = percentage points

About INSPIREMD 1/18 DL-0001

F:II2 Germany Medical Devices
Market Cap
$19.63 Million
€16.79 Million EUR
Market Cap Rank
#25021 Global
#2153 in Germany
Share Price
€0.36
Change (1 day)
+7.83%
52-Week Range
€0.30 - €1.90
All Time High
€193594.95
About

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard c… Read more